Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.280
+0.050 (4.07%)
At close: Jan 7, 2026, 4:00 PM EST
1.272
-0.008 (-0.63%)
After-hours: Jan 7, 2026, 6:59 PM EST
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $28.65 million as of January 7, 2026. Its market cap has decreased by -48.60% in one year.
Market Cap
28.65M
Enterprise Value
-40.28M
1-Year Change
-48.60%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $28.65M, a decrease of -91.95%. That is a compound annual growth rate of -75.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 27.53M | 2.50% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 933.49B |
| Johnson & Johnson | 487.04B |
| AbbVie | 385.41B |
| UnitedHealth Group | 307.99B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.91B |
| Novo Nordisk | 230.76B |